The STOP-HPV Trial 1: Communication Intervention
Completed · Not applicable
Conditions studied: Immunization, Vaccination
In brief
Most adolescents who receive human papillomavirus (HPV) vaccine are vaccinated in pediatric practices, yet missed opportunities (MOs) for HPV vaccination occur often and lead to low HPV vaccination rates. This cluster randomized clinical trial (RCT) will test the effectiveness (and cost-effectiveness) of training providers on HPV vaccine communication to reduce MOs and increase HPV vaccination rates.
Key facts
- Study ID
- NCT03599557
- Run by
- University of California, Los Angeles
- People needed
- 48
- Starts
- 2018-08-07
- Expected to finish
- 2019-10-21
- Last updated by the study team
- 2024-07-12
Who can join
Age: 11 and older, up to 17. Sex: any. Healthy volunteers: accepted.
Where it is running
- American Academy of Pediatrics — Itasca, Illinois, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.